On October 26, Synopsys posted an Intraday Rise of 3.05% in Regular Trading, trading at $443.5 per share with turnover of $80.9877 million.
The move appears linked to continued positive sentiment after recent analyst target-price increases.
Recent updates show Morgan Stanley raised its target price to $574 from $500 on October 20, following Needham's increase to $620 from $580 on October 12. FactSet-polled analysts carried an average buy rating and a mean target price of $582.08 in the more recent update, reinforcing constructive medium-term expectations. Earlier catalysts also included a more than $1 billion multi-year strategic IP agreement with Amazon, a $1 billion accelerated share repurchase plan, and fiscal 2027 targets calling for about $11.15 billion in revenue at the midpoint.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments